The Rotterdam Study (ERGO-onderzoek in Dutch)

The Rotterdam Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON23050

Enrollment

19000

Registered

2017-11-13

Start date

1989-07-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular, endocrine, hepatic, neurological, ophthalmic, psychiatric, dermatological, otolaryngological, locomotor, and respiratory diseases

Interventions

None, observational cohort study

Eligibility

Inclusion criteria

Inclusion criteria: Members of the public, aged 40 years and over, living in the Ommoord district in the city of Rotterdam, The Netherlands

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Clinical and subclinical outcomes in the cardiovascular, endocrine, hepatic, neurological, ophthalmic, psychiatric, dermatological, otolaryngological, locomotor, and respiratory research domain	—

Contacts

Public ContactRotterdam Study Office

PO Box 2040

secretariat.epi@erasmusmc.nl00 31 (0)10 704 34 88

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)